Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:955-962

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomochika, Y.
Right arrow Articles by Matsuzaki, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomochika, Y.
Right arrow Articles by Matsuzaki, M.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:955-962.)
© 1996 American Heart Association, Inc.


Articles

Improvement of Atherosclerosis and Stiffness of the Thoracic Descending Aorta With Cholesterol-Lowering Therapies in Familial Hypercholesterolemia

Yasuaki Tomochika; Fumio Okuda; Nobuaki Tanaka; Yuichiro Wasaki; Ikuo Tokisawa; Shumpei Aoyagi; Chieko Morikuni; Shiro Ono; Kazuyoshi Okada; Masunori Matsuzaki

the Second Department of Internal Medicine and Clinical Laboratory Science, Yamaguchi University School of Medicine, Yamaguchi, Japan. Presented in part at the 66th Scientific Sessions of the American Heart Association, Atlanta, Ga, November 8-11, 1993.

Correspondence to Masunori Matsuzaki, MD, PhD, The Second Department of Internal Medicine, Yamaguchi University School of Medicine, 1144 Kogushi, Ube, Yamaguchi 755, Japan.

The thoracic aorta is frequently involved in atherosclerotic lesions associated with familial hypercholesterolemia (FH). Transesophageal echocardiography (TEE) allows quantitative evaluation of the wall properties of the thoracic aorta. Using TEE, we tested whether atherosclerosis of the thoracic aorta in FH could be improved by cholesterol-lowering therapies. The subjects investigated were 22 FH patients and 22 age-matched normal subjects. The descending aorta (DA) was divided into four longitudinal portions of equal length. Atheromatous lesions of each portion of the DA were scored by character and extension of lesions by biplane two-dimensional TEE. The scores of atheromatous lesions from all four portions of the DA were added together to give the total atheromatous score (TAS). We also measured instantaneous dimensional changes of the DA in a cardiac cycle by M-mode TEE and blood pressure by a cuff method and calculated the stiffness parameter ß (ln[SBP/DBP]/[Dmax-Dmin]/Dmin), where SBP is the systolic arterial blood pressure, DBP is the diastolic arterial blood pressure, Dmax is the maximum aortic dimension during the ejection period, and Dmin is the minimum aortic dimension during the preejection period. TAS was higher in FH (3.70±1.32) than normal (0.62±0.54, P<.0001) subjects. ß in FH (10.35±4.87) was greater than in normal (5.10±1.25, P<.0001) subjects, but there were no significant differences of DA dimensions between the groups. In both normal subjects and FH patients, ß correlated with age (r=.52, P<.02 and r=.59, P<.005, respectively). In FH patients, ß and TAS correlated well with pretreatment total cholesterol levels (r=.43, P<.05 and r=.60, P<.005, respectively). In 12 of 22 FH patients, strict cholesterol-lowering therapies with diet and cholesterol-lowering drugs (pravastatin and probucol) were undertaken for 13 months. Cholesterol levels were significantly decreased from 333±45 to 219±39 mg/dL (P<.0001); this was associated with significant decreases in ß and TAS (from 9.88±5.03 to 7.88±3.92, P<.005, and from 3.61±1.50 to 2.94±1.22, P<.0005, respectively). In FH patients, the incidence and severity of morphological and physiological atherosclerosis of the DA were significantly higher than in age-matched normal subjects. A significant regression of atherosclerosis was achieved by strict cholesterol-lowering therapies in relatively young FH patients.


Key Words: transesophageal echocardiography • atherosclerosis • thoracic descending aorta • familial hypercholesterolemia • cholesterol-lowering therapy




This article has been cited by other articles:


Home page
CirculationHome page
R. N. Khouzam
Mobile Aortic Atheroma Leading to a Cerebrovascular Accident
Circulation, February 10, 2009; 119(5): e192 - e192.
[Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
S. De Castro, E. Di Angelantonio, A. Celotto, M. Fiorelli, I. Passaseo, F. Papetti, S. Caselli, A. Marcantonio, A. Cohen, and N. Pandian
Short-term evolution (9 months) of aortic atheroma in patients with or without embolic events: a follow-up transoesophageal echocardiographic study
Eur J Echocardiogr, January 1, 2009; 10(1): 96 - 102.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
K. Prasad
A Study on Regression of Hypercholesterolemic Atherosclerosis in Rabbits by Flax Lignan Complex
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2007; 12(4): 304 - 313.
[Abstract] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
D. Bainbridge
Aortic assessment for cardiac surgical procedures.
Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2006; 10(2): 158 - 161.
[Abstract] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
G. Saliashvili, W. W. Davis, M. T. Harris, N.-A. Le, and W. V. Brown
Simvastatin Improved Arterial Compliance in High-Risk Patients
Vascular and Endovascular Surgery, November 1, 2004; 38(6): 519 - 523.
[Abstract] [PDF]


Home page
Eur Heart JHome page
R. Arroyo-Espliguero, N. Mollichelli, P. Avanzas, E. Zouridakis, V. R Newey, D. K Nassiri, and J. C. Kaski
Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X
Eur. Heart J., November 2, 2003; 24(22): 2006 - 2011.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. J. Oliver and D. J. Webb
Noninvasive Assessment of Arterial Stiffness and Risk of Atherosclerotic Events
Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 554 - 566.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Sugioka, T. Hozumi, R. R. Sciacca, Y. Miyake, I. Titova, G. Gaspard, R. L. Sacco, S. Homma, and M. R. Di Tullio
Impact of Aortic Stiffness on Ischemic Stroke in Elderly Patients
Stroke, August 1, 2002; 33(8): 2077 - 2081.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Sen, S. M. Oppenheimer, J. Lima, and B. Cohen
Risk Factors for Progression of Aortic Atheroma in Stroke and Transient Ischemic Attack Patients
Stroke, April 1, 2002; 33(4): 930 - 935.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. E. Ferrier, M. H. Muhlmann, J.-P. Baguet, J. D. Cameron, G. L. Jennings, A. M. Dart, and B. A. Kingwell
Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension
J. Am. Coll. Cardiol., March 20, 2002; 39(6): 1020 - 1025.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. J. Willens and K. M. Kessler
Transesophageal Echocardiography in the Diagnosis of Diseases of the Thoracic Aorta* : Part II--Atherosclerotic and Traumatic Diseases of the Aorta
Chest, January 1, 2000; 117(1): 233 - 243.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. O. Toikka, P. Niemi, M. Ahotupa, H. Niinikoski, J. S. A. Viikari, T. Ronnemaa, J. J. Hartiala, and O. T. Raitakari
Large-Artery Elastic Properties in Young Men : Relationships to Serum Lipoproteins and Oxidized Low-Density Lipoproteins
Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 436 - 441.
[Abstract] [Full Text] [PDF]